Although primary malignancies of bone are rare, thousands of benign bone tumors are diagnosed annually. It is important to be able to distinguish benign lesions from malignant lesions and differentiate those lesions that can be watched versus lesions that require further treatment and referral to an orthopaedic oncologist. Learning to distinguish these entities and their appropriate treatment or triage will positively affect the patient and the surgeon's practice.



Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
100% Article relates to my practice (3/3)
0% Article does not relate to my practice (0/3)
0% Undecided (0/3)
2

Will this article lead to more cost-effective healthcare?

66% Yes (2/3)
33% No (1/3)
0% Undecided (0/3)
3

Was this article biased? (commercial or personal)

0% Yes (0/3)
100% No (3/3)
0% Undecided (0/3)
4

What level of evidence do you think this article is?

0% Level 1 (0/3)
0% Level 2 (0/3)
66% Level 3 (2/3)
33% Level 4 (1/3)
0% Level 5 (0/3)